A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer

por Kote-Jarai, Z, Jugurnauth, S, Mulholland, S, Leongamornlert, D A, Guy, M, Edwards, S, Tymrakiewitcz, M, O'Brien, L, Hall, A, Wilkinson, R, Al Olama, A A, Morrison, J, Muir, K, Neal, D, Donovan, J, Hamdy, F, Easton, D F, Eeles, R
Publicado 2009

Pattern of cancer risk in persons with AIDS in Italy in the HAART era

por Dal Maso, L, Polesel, J, Serraino, D, Lise, M, Piselli, P, Falcini, F, Russo, A, Intrieri, T, Vercelli, M, Zambon, P, Tagliabue, G, Zanetti, R, Federico, M, Limina, R M, Mangone, L, De Lisi, V, Stracci, F, Ferretti, S, Piffer, S, Budroni, M, Donato, A, Giacomin, A, Bellù, F, Fusco, M, Madeddu, A, Vitarelli, S, Tessandori, R, Tumino, R, Suligoi, B, Franceschi, S
Publicado 2009

Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer

por Roxburgh, C S D, Crozier, J E M, Maxwell, F, Foulis, A K, Brown, J, McKee, R F, Anderson, J H, Horgan, P G, McMillan, D C
Publicado 2009

Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy

por Kiserud, C E, Fosså, A, Bjøro, T, Holte, H, Cvancarova, M, Fosså, S D
Publicado 2009

Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation

por Rahman, M M, Qian, Z R, Wang, E L, Sultana, R, Kudo, E, Nakasono, M, Hayashi, T, Kakiuchi, S, Sano, T
Publicado 2009

Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis

por Abnet, C C, Freedman, N D, Kamangar, F, Leitzmann, M F, Hollenbeck, A R, Schatzkin, A
Publicado 2009

The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

por Diaz, R, Nguewa, P A, Diaz-Gonzalez, J A, Hamel, E, Gonzalez-Moreno, O, Catena, R, Serrano, D, Redrado, M, Sherris, D, Calvo, A
Publicado 2009

The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer

por Trinh, X B, Tjalma, W A A, Vermeulen, P B, Van den Eynden, G, Van der Auwera, I, Van Laere, S J, Helleman, J, Berns, E M J J, Dirix, L Y, van Dam, P A
Publicado 2009

Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas

por Torres-Rendon, A, Roy, S, Craig, G T, Speight, P M
Publicado 2009

The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer

por Horlock, C, Stott, B, Dyson, P J, Morishita, M, Coombes, R C, Savage, P, Stebbing, J
Publicado 2009

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

por Van der Auwera, I, Elst, H J, Van Laere, S J, Maes, H, Huget, P, van Dam, P, Van Marck, E A, Vermeulen, P B, Dirix, L Y
Publicado 2009

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis

por Schoenleber, S J, Kurtz, D M, Talwalkar, J A, Roberts, L R, Gores, G J
Publicado 2009

Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity

por Coleman, L J, Peter, M B, Teall, T J, Brannan, R A, Hanby, A M, Honarpisheh, H, Shaaban, A M, Smith, L, Speirs, V, Verghese, E T, McElwaine, J N, Hughes, T A
Publicado 2009

Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies

por Velentzis, L S, Cantwell, M M, Cardwell, C, Keshtgar, M R, Leathem, A J, Woodside, J V
Publicado 2009

Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells

por Sahu, R P, Batra, S, Srivastava, S K
Publicado 2009

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo

por Cejka, D, Kuntner, C, Preusser, M, Fritzer-Szekeres, M, Fueger, B J, Strommer, S, Werzowa, J, Fuereder, T, Wanek, T, Zsebedics, M, Mueller, M, Langer, O, Wacheck, V
Publicado 2009

Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-κB-dependent activation of the urokinase plasminogen activator system

por Killeen, S D, Wang, J H, Andrews, E J, Redmond, H P
Publicado 2009

TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk

por Skoglund Lundin, J, Vandrovcova, J, Song, B, Zhou, X, Zelada-Hedman, M, Werelius, B, Houlston, R S, Lindblom, A
Publicado 2009

Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma

por Noda, T, Nagano, H, Takemasa, I, Yoshioka, S, Murakami, M, Wada, H, Kobayashi, S, Marubashi, S, Takeda, Y, Dono, K, Umeshita, K, Matsuura, N, Matsubara, K, Doki, Y, Mori, M, Monden, M
Publicado 2009

Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

por Ferrucci, L M, Cross, A J, Graubard, B I, Brinton, L A, McCarty, C A, Ziegler, R G, Ma, X, Mayne, S T, Sinha, R
Publicado 2009